Boston Scientific Corporation

NYSE:BSX

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

🩺 Medical Instruments

Location

United States

Market Cap

USD 157.95 B

Share Price

USD 106.76

Avg Daily Volume

7,467,491

Change (1 day)

0.27%

Change (1 year)

44.21%

Change (YTD)

19.53%

Boston Scientific Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2025: USD 3.81 B

Boston Scientific Corporation Operating Cash Flow is USD 3.81 B for the Trailing 12 Months (TTM) ending March 31, 2025, a 53.90% change year over year. Operating cash flow is cash generated from the company’s regular business operations.

Boston Scientific Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 2.48 B, a 39.63% change year over year.
Boston Scientific Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 1.77 B, a 16.10% change year over year.
Boston Scientific Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 1.53 B, a -18.25% change year over year.
Boston Scientific Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 1.87 B, a 32.65% change year over year.